Yellow card myocarditis advisory
June 17, 2026
21 min
Full
199 of 364
June 17, 2026
Yellow card myocarditis advisory
0:00 / 21:24
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Dr John Campbell Episodes Around June 17, 2026
Episode 199 of 364 — walk the feed in the order it was published.
21:24This episodeYellow card myocarditis advisory
Summary
Yellow card scheme, Don’t wait for someone else to report it
https://www.gov.uk/drug-safety-update/yellow-card-please-help-to-reverse-the-decline-in-reporting-of-suspected-adverse-drug-reactions
It is estimated that only 10% of serious reactions and between 2 and 4% of non-serious reactions are reported.
Yellow card government site, just a click away
https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting
As of 23 November 2022, (UK)
Pfizer/BioNTech, monovalent and bivalent
177,925 Yellow Cards have been reported
AstraZeneca
246,866 have been reported
Moderna, monovalent and bivalent
47,045 have been reported
Novavax
52 reports
Brand of vaccine was not specified
2,130 reports
Total reports
474,018
Overall reporting rate
Around 2 to 5 Yellow Cards per 1,000 doses administered
In the 28 days
Pfizer/BioNTech, + 2,499 reports
AstraZeneca, + 228
Moderna, + 1,099
Novavax, + 15
Brand not specified, + 154
For all COVID-19 vaccines
injection-site reactions (sore arm for example)
generalised symptoms such as ‘flu-like’ illness
headache, chills, fatigue (tiredness), nausea (feeling sick), fever, dizziness, weakness, aching muscles, rapid heartbeat
they may be reported more frequently in younger adults
Overall, our advice remains that the benefits of the vaccines outweigh the risks in the majority of people.
The benefits of the vaccines in preventing COVID-19 and serious complications associated with COVID-19 far outweigh any currently known side effects in the majority of patients.
https://wchh.onlinelibrary.wiley.com/doi/pdf/10.1002/psb.1789
Google YT guidelines
https://support.google.com/youtube/answer/9891785
Claims that an approved COVID-19 vaccine will cause death, infertility, miscarriage, autism, or contraction of other infectious diseases
https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/information-for-healthcare-professionals-on-covid-19-vaccine-moderna
4.4 Special warnings and precautions for use
Hypersensitivity and anaphylaxis
Anaphylaxis has been reported in individuals who have received Spikevax.
Close observation for at least 15 minutes is recommended following vaccination.